Background: Surveillance of antimicrobial resistance (AMR) requires an international approach with national and local strategies. Our aim was to summarize a retrospective 10-year report of antibiotic resistance of gram-positive and gram-negative bacteria in Mexico. Methods: A total of 46 centers from 22 states of Mexico participated. Databases of AMR from January 2009 to December 2018 were included for most species. The 10-year period was divided into five 2-year periods. Results: For Staphylococcus aureus, a decrease in resistance in all specimens was observed for erythromycin and oxacillin (p < 0.0001 for each). For Enterobacter spp., resistance to meropenem increased for urine specimens (p = 0.0042). For Klebsiella spp., increased drug resistance in specimens collected from blood was observed for trimethoprim/sulfamethoxazole, gentamicin, tobramycin (p < 0.0001 for each), meropenem (p = 0.0014), and aztreonam (p = 0.0030). For Acinetobacter baumannii complex, high drug resistance was detected for almost all antibiotics, including carbapenems, except for tobramycin, which showed decreased resistance for urine, respiratory, and blood isolates (p < 0.0001 for each), and for amikacin, which showed a decrease in resistance in urine specimens (p = 0.0002). An increase in resistance to cefepime was found for urine, respiratory, and blood specimens (p < 0.0001 for each). For Pseudomonas aeruginosa, aztreonam resistance increased for isolates recovered from blood (p = 0.0001). Conclusion: This laboratory-based surveillance of antibiotic resistance shows that resistance is increasing for some antibiotics in different bacterial species in Mexico and highlights the need for continuous monitoring of antibiotic resistance.
Background: Surveillance of antimicrobial resistance (AMR) requires an international approach with national and local strategies. Our aim was to summarize a retrospective 10-year report of antibiotic resistance of gram-positive and gram-negative bacteria in Mexico. Methods: A total of 46 centers from 22 states of Mexico participated. Databases of AMR from January 2009 to December 2018 were included for most species. The 10-year period was divided into five 2-year periods. Results: For Staphylococcus aureus, a decrease in resistance in all specimens was observed for erythromycin and oxacillin (p < 0.0001 for each). For Enterobacter spp., resistance to meropenem increased for urine specimens (p = 0.0042). For Klebsiella spp., increased drug resistance in specimens collected from blood was observed for trimethoprim/sulfamethoxazole, gentamicin, tobramycin (p < 0.0001 for each), meropenem (p = 0.0014), and aztreonam (p = 0.0030). For Acinetobacter baumannii complex, high drug resistance was detected for almost all antibiotics, including carbapenems, except for tobramycin, which showed decreased resistance for urine, respiratory, and blood isolates (p < 0.0001 for each), and for amikacin, which showed a decrease in resistance in urine specimens (p = 0.0002). An increase in resistance to cefepime was found for urine, respiratory, and blood specimens (p < 0.0001 for each). For Pseudomonas aeruginosa, aztreonam resistance increased for isolates recovered from blood (p = 0.0001). Conclusion: This laboratory-based surveillance of antibiotic resistance shows that resistance is increasing for some antibiotics in different bacterial species in Mexico and highlights the need for continuous monitoring of antibiotic resistance.
Authors: Elvira Garza-González; Paola Bocanegra-Ibarias; Miriam Bobadilla-Del-Valle; Luis Alfredo Ponce-de-León-Garduño; Verónica Esteban-Kenel; Jesus Silva-Sánchez; Ulises Garza-Ramos; Humberto Barrios-Camacho; Luis Esaú López-Jácome; Claudia A Colin-Castro; Rafael Franco-Cendejas; Samantha Flores-Treviño; Rayo Morfín-Otero; Fabian Rojas-Larios; Juan Pablo Mena-Ramírez; María Guadalupe Fong-Camargo; Cecilia Teresita Morales-De-la-Peña; Lourdes García-Mendoza; Elena Victoria Choy-Chang; Laura Karina Aviles-Benitez; José Manuel Feliciano-Guzmán; Eduardo López-Gutiérrez; Mariana Gil-Veloz; Juan Manuel Barajas-Magallón; Efren Aguirre-Burciaga; Laura Isabel López-Moreno; Rebeca Thelma Martínez-Villarreal; Jorge Luis Canizales-Oviedo; Carlos Miguel Cetina-Umaña; Daniel Romero-Romero; Fidencio David Bello-Pazos; Nicolás Rogelio Eric Barlandas-Rendón; Joyarib Yanelli Maldonado-Anicacio; Enrique Bolado-Martínez; Mario Galindo-Méndez; Talia Perez-Vicelis; Norma Alavez-Ramírez; Braulio J Méndez-Sotelo; Juan Francisco Cabriales-Zavala; Yirla Citlali Nava-Pacheco; Martha Irene Moreno-Méndez; Ricardo García-Romo; Aldo Rafael Silva-Gamiño; Ana María Avalos-Aguilera; María Asunción Santiago-Calderón; Maribel López-García; María Del Consuelo Velázquez-Acosta; Dulce Isabel Cobos-Canul; María Del Rosario Vázquez-Larios; Ana Elizabeth Ortiz-Porcayo; Arely Elizabeth Guerrero-Núñez; Jazmín Valero-Guzmán; Alina Aracely Rosales-García; Heidy Leticia Ostos-Cantú; Adrián Camacho-Ortiz Journal: PLoS One Date: 2021-03-17 Impact factor: 3.240